R. Vega
发表
L. Possani,
R. Vega,
2006
.
J. Gouzy,
T. Giraud,
J. Dupont,
2016
.
L. Possani,
R. Vega,
2003
.
P. Gopalakrishnakone,
E. F. Schwartz,
R. Vega,
2015,
Toxinology.
L. Possani,
N. Vidal,
R. Vega,
2013
.
Y. Rosenstein,
G. Pedraza-Alva,
L. Possani,
2012
.
G. Pedraza-Alva,
L. Possani,
R. Tajhya,
2012
.
H. Sadoff,
R. Vega,
M. Patterson,
1976,
Antimicrobial Agents and Chemotherapy.
E. Wanke,
L. Possani,
G. Pimienta,
2004
.
Tom O. Delmont,
N. Chrismas,
Claudia Chica,
2019,
Reference Module in Biomedical Sciences.
T. Giraud,
J. Dupont,
R. Debuchy,
2022
.
J. Tytgat,
L. Possani,
E. F. Schwartz,
2007,
Cellular and Molecular Life Sciences.
L. Possani,
E. F. Schwartz,
C. Batista,
2007,
Peptides.
T. Giraud,
J. Dupont,
J. Houbraken,
2023
.
T. Giraud,
R. Vega,
2021,
Peer Community In Genomics.
K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression.
R. C. Rodríguez de la Vega,
L. Possani,
R. Gáspár,
2006,
Current pharmaceutical design.
A. Scaloni,
R. C. Rodríguez de la Vega,
L. Possani,
2004,
Cellular and Molecular Life Sciences CMLS.
L. Possani,
N. A. Valdez-Cruz,
G. Panyi,
2005
.
L. Possani,
N. A. Valdez-Cruz,
G. Panyi,
2005
.
L. Possani,
N. A. Valdez-Cruz,
G. Panyi,
2005
.